ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,1,Cardioactive drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
4,2,Cardioactive drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5,2,Cardioactive drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
6,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7,2,Cardioactive drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
7,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
10,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
11,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
11,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
12,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
13,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
